600866 Stock Overview
Star Lake Bioscience Co., Inc. engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 600866 from our risk checks.
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.09 |
| 52 Week High | CN¥6.08 |
| 52 Week Low | CN¥3.35 |
| Beta | 0.27 |
| 1 Month Change | 17.01% |
| 3 Month Change | 14.64% |
| 1 Year Change | -15.87% |
| 3 Year Change | 32.90% |
| 5 Year Change | -5.74% |
| Change since IPO | 244.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600866 | CN Food | CN Market | |
|---|---|---|---|
| 7D | 22.7% | 2.0% | -0.4% |
| 1Y | -15.9% | -19.2% | -14.4% |
Return vs Industry: 600866 exceeded the CN Food industry which returned -19.2% over the past year.
Return vs Market: 600866 underperformed the CN Market which returned -14.4% over the past year.
Price Volatility
| 600866 volatility | |
|---|---|
| 600866 Average Weekly Movement | 7.3% |
| Food Industry Average Movement | 6.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600866's share price has been volatile over the past 3 months.
Volatility Over Time: 600866's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 8,908 | Ying Jun | www.starlake.com.cn |
Star Lake Bioscience Co., Inc. engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroying Hepatitis B virus DNA; and L-threonine that is used in premixtures, and pig and poultry feed. It also provides disodium 5’-ribonucleotide to cure chronic hepatitis, muscular atrophy, and eye diseases; disodium 5-inosinate to cure leukopenia, thrombocytopenia, and chronic and acute hepatitis; and inosine, which is used for the treatment of chronic hepatitis, heart disease, leukopenia or thrombocytopenia, central choroidoretinitis, etc. In addition, the company offers disodium 5’-guanylate for canned and salted meat, ham, etc. Further, it provides ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, L-threonine, L-lysine, etc. Star Lake Bioscience Co., Inc. was founded in 1964 and is based in Zhaoqing, China.
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Fundamentals Summary
| 600866 fundamental statistics | |
|---|---|
| Market cap | CN¥8.46b |
| Earnings (TTM) | CN¥808.92m |
| Revenue (TTM) | CN¥17.41b |
10.5x
P/E Ratio0.5x
P/S RatioIs 600866 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600866 income statement (TTM) | |
|---|---|
| Revenue | CN¥17.41b |
| Cost of Revenue | CN¥14.82b |
| Gross Profit | CN¥2.59b |
| Other Expenses | CN¥1.78b |
| Earnings | CN¥808.92m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.49 |
| Gross Margin | 14.87% |
| Net Profit Margin | 4.65% |
| Debt/Equity Ratio | 54.9% |
How did 600866 perform over the long term?
See historical performance and comparison